This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
New Data, Case Studies & Partners
September 4th-5th, 2024San Diego Convention Center, USA

Josh Mandel-Brehm
CEO at Camp4 Therapeutics
Speaker

Profile

Josh Mandel-Brehm is President & Chief Executive Officer of CAMP4 Therapeutics.

Mr. Mandel-Brehm was previously an entrepreneur partner with Polaris Partners and held key business development and operations leadership roles at leading biotech companies. Most recently he served as part of the Business Development group at Biogen, where he led multiple strategic activities and corresponding transactions. Prior to Biogen, Mr. Mandel-Brehm held several roles of increasing responsibility at Genzyme as part of the business development group for the company’s rare disease business unit.

Mr. Mandel-Brehm earned a BA in Biology from Washington University in St. Louis and holds an MBA from the University of Michigan.

Agenda Sessions

  • EXPLORING regRNA AS A NEW THERAPEUTIC TARGET IN METABOLIC AND CNS DISEASES

    12:10pm
  • THE FUTURE OF RNA THERAPEUTICS

    4:15pm